We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RGBAD market cap is 13.66M. The company's latest EPS is USD 0.3422 and P/E is 5.87.
| Year End 30 September 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 236k | 237k |
| Operating Income | -339k | -686k |
| Net Income | 2.44M | 1.16M |
| Year End 30 September 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 559k | 354k |
| Total Liabilities | 8.6M | 5.46M |
| Total Equity | -8.04M | -5.1M |
| Year End 30 September 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Operating | -607k | -174k |
| Investing | 25k | N/A |
| Financing | -94k | 244k |
| Market Cap | 13.66M |
| Price to Earnings Ratio | 5.87 |
| Price to Sales Ratio | 28.67 |
| Price to Cash Ratio | 56.15 |
| Price to Book Ratio | -1.33 |
| Dividend Yield | - |
| Shares Outstanding | 3.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 26.49 (88.3%) |
| Company Name | Regen Biopharma Inc (PK) |
| Address |
50 west liberty street, suite 880 reno, nevada 89501 |
| Website | https://www.regenbiopharmainc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
